Fever
View on Wikipedia
| Fever | |
|---|---|
| Other names | Pyrexia, febrile response, febrile[1] |
| Person with fever | |
| Specialty | Infectious disease, pediatrics |
| Symptoms | Initially: shivering, feeling cold, chills[2] Later: flushed, sweating[3] |
| Complications | Febrile seizure[4] |
| Causes | Virus, bacteria, increase in the body's temperature set point[5][6] |
| Diagnostic method | Temperature higher than the normal range of 37.2 and 38.3 °C (99.0 and 100.9 °F)[1][7][8] |
| Differential diagnosis | Hyperthermia[1] |
| Treatment | Based on underlying cause, not required for fever itself[2][9] |
| Medication | Ibuprofen, paracetamol (acetaminophen)[9][10] |
| Frequency | Common[2][11] |
Fever or pyrexia in humans is a symptom of an anti-infection defense mechanism that appears with body temperature exceeding the normal range caused by an increase in the body's temperature set point in the hypothalamus.[5][6][7][12] There is no single agreed-upon upper limit for normal temperature: sources use values ranging between 37.2 and 38.3 °C (99.0 and 100.9 °F) in humans.[1][7][8]
The increase in set point triggers increased muscle contractions and causes a feeling of cold or chills.[2] This results in greater heat production and efforts to conserve heat.[3] When the set point temperature returns to normal, a person feels hot, becomes flushed, and may begin to sweat.[3] Rarely a fever may trigger a febrile seizure, with this being more common in young children.[4] Fevers do not typically go higher than 41 to 42 °C (106 to 108 °F).[6]
A fever can be caused by many medical conditions ranging from non-serious to life-threatening.[13] This includes viral, bacterial, and parasitic infections—such as influenza, the common cold, meningitis, urinary tract infections, appendicitis, Lassa fever, COVID-19, and malaria.[13][14] Non-infectious causes include vasculitis, deep vein thrombosis, connective tissue disease, side effects of medication or vaccination, and cancer.[13][15] It differs from hyperthermia, in that hyperthermia is an increase in body temperature over the temperature set point, due to either too much heat production or not enough heat loss.[1]
Treatment to reduce fever is generally not required.[2][9] Treatment of associated pain and inflammation, however, may be useful and help a person rest.[9] Medications such as ibuprofen or paracetamol (acetaminophen) may help with this as well as lower temperature.[9][10] Children younger than three months require medical attention, as might people with serious medical problems such as a compromised immune system or people with other symptoms.[16] Hyperthermia requires treatment.[2]
Fever is one of the most common medical signs.[2] It is part of about 30% of healthcare visits by children[2] and occurs in up to 75% of adults who are seriously sick.[11] While fever evolved as a defense mechanism, treating a fever does not appear to improve or worsen outcomes.[17][18][19] Fever is often viewed with greater concern by parents and healthcare professionals than is usually deserved, a phenomenon known as "fever phobia."[2][20]
Associated symptoms
[edit]A fever is usually accompanied by sickness behavior, which consists of lethargy, depression, loss of appetite, sleepiness, hyperalgesia, dehydration,[21][22] and the inability to concentrate. Sleeping with a fever can often cause intense or confusing nightmares, commonly called "fever dreams".[23] Mild to severe delirium (which can also cause hallucinations) may also present itself during high fevers.[24]
Differential diagnosis
[edit]Hyperthermia
[edit]Hyperthermia is an elevation of body temperature over the temperature set point, due to either too much heat production or not enough heat loss.[1][7] Hyperthermia is thus not considered fever.[7]: 103 [25] Hyperthermia should not be confused with hyperpyrexia (which is a very high fever).[7]: 102
Clinically, it is important to distinguish between fever and hyperthermia as hyperthermia may quickly lead to death and does not respond to antipyretic medications. The distinction may however be difficult to make in an emergency setting, and is often established by identifying possible causes.[7]: 103
Mechanism
[edit]Hypothalamus
[edit]Temperature is regulated in the hypothalamus. The trigger of a fever, called a pyrogen, results in the release of prostaglandin E2 (PGE2). PGE2 in turn acts on the hypothalamus, which creates a systemic response in the body, causing heat-generating effects to match a new higher temperature set point. There are four receptors in which PGE2 can bind (EP1-4), with a previous study showing the EP3 subtype is what mediates the fever response.[26] Hence, the hypothalamus can be seen as working like a thermostat.[7] When the set point is raised, the body increases its temperature through both active generation of heat and retention of heat. Peripheral vasoconstriction both reduces heat loss through the skin and causes the person to feel cold. Norepinephrine increases thermogenesis in brown adipose tissue, and muscle contraction through shivering raises the metabolic rate.[27]
If these measures are insufficient to make the blood temperature in the brain match the new set point in the hypothalamus, the brain orchestrates heat effector mechanisms via the autonomic nervous system or primary motor center for shivering. These may be:[28][29][30]
- Increased heat production by increased muscle tone, shivering (muscle movements to produce heat) and release of hormones like epinephrine; and
- Prevention of heat loss, e.g., through vasoconstriction.
When the hypothalamic set point moves back to baseline—either spontaneously or via medication—normal functions such as sweating, and the reverse of the foregoing processes (e.g., vasodilation, end of shivering, and nonshivering heat production) are used to cool the body to the new, lower setting.[citation needed]
This contrasts with hyperthermia, in which the normal setting remains, and the body overheats through undesirable retention of excess heat or over-production of heat. Hyperthermia is usually the result of an excessively hot environment (heat stroke) or an adverse reaction to drugs. Fever can be differentiated from hyperthermia by the circumstances surrounding it and its response to anti-pyretic medications.[7][verification needed]
In infants, the autonomic nervous system may also activate brown adipose tissue to produce heat (non-shivering thermogenesis).[31]
Increased heart rate and vasoconstriction contribute to increased blood pressure in fever.[32]
Pyrogens
[edit]A pyrogen is a substance that induces fever.[33] In the presence of an infectious agent, such as bacteria, viruses, viroids, etc., the immune response of the body is to inhibit their growth and eliminate them. The most common pyrogens are endotoxins, which are lipopolysaccharides (LPS) produced by Gram-negative bacteria such as E. coli. But pyrogens include non-endotoxic substances (derived from microorganisms other than gram-negative-bacteria or from chemical substances) as well.[34] The types of pyrogens include internal (endogenous) and external (exogenous) to the body.[35]
The "pyrogenicity" of given pyrogens varies: in extreme cases, bacterial pyrogens can act as superantigens and cause rapid and dangerous fevers.[36]
Endogenous
[edit]Endogenous pyrogens are cytokines released from monocytes (which are part of the immune system).[37] In general, they stimulate chemical responses, often in the presence of an antigen, leading to a fever. Whilst they can be a product of external factors like exogenous pyrogens, they can also be induced by internal factors like damage associated molecular patterns such as cases like rheumatoid arthritis or lupus.[38]
Major endogenous pyrogens are interleukin 1 (α and β)[39]: 1237–1248 and interleukin 6 (IL-6).[40] Minor endogenous pyrogens include interleukin-8, tumor necrosis factor-β, macrophage inflammatory protein-α and macrophage inflammatory protein-β as well as interferon-α, interferon-β, and interferon-γ.[39]: 1237–1248 Tumor necrosis factor-α (TNF) also acts as a pyrogen, mediated by interleukin 1 (IL-1) release.[41] These cytokine factors are released into general circulation, where they migrate to the brain's circumventricular organs where they are more easily absorbed than in areas protected by the blood–brain barrier.[42] The cytokines then bind to endothelial receptors on vessel walls to receptors on microglial cells, resulting in activation of the arachidonic acid pathway.[43]
Of these, IL-1β, TNF, and IL-6 are able to raise the temperature setpoint of an organism and cause fever. These proteins produce a cyclooxygenase which induces the hypothalamic production of PGE2 which then stimulates the release of neurotransmitters such as cyclic adenosine monophosphate and increases body temperature.[44]
Exogenous
[edit]Exogenous pyrogens are external to the body and are of microbial origin. In general, these pyrogens, including bacterial cell wall products, may act on Toll-like receptors in the hypothalamus and elevate the thermoregulatory setpoint.[45]
An example of a class of exogenous pyrogens are bacterial lipopolysaccharides (LPS) present in the cell wall of gram-negative bacteria. According to one mechanism of pyrogen action, an immune system protein, lipopolysaccharide-binding protein (LBP), binds to LPS, and the LBP–LPS complex then binds to a CD14 receptor on a macrophage. The LBP-LPS binding to CD14 results in cellular synthesis and release of various endogenous cytokines, e.g., interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNFα). A further downstream event is activation of the arachidonic acid pathway.[46]
Neural circuit mechanism with PGE2 action
[edit]PGE2 release comes from the arachidonic acid pathway. This pathway (as it relates to fever), is mediated by the enzymes phospholipase A2 (PLA2), cyclooxygenase-2 (COX-2), and prostaglandin E2 synthase. These enzymes ultimately mediate the synthesis and release of PGE2.[47]
PGE2 is the ultimate mediator of the febrile response. The setpoint temperature of the body will remain elevated until PGE2 is no longer present. PGE2 acts on neurons in the preoptic area (POA) through the prostaglandin E receptor 3 (EP3).[48][49][50][51] EP3-expressing neurons in the POA innervate the dorsomedial hypothalamus (DMH),[52][53] the rostral raphe pallidus nucleus in the medulla oblongata (rRPa),[49][53] and the paraventricular nucleus (PVN) of the hypothalamus.[54] Under normal conditions, EP3-expressing neurons in the POA are important thermoregulatory neurons, which provide continuous inhibitory signals with the transmitter GABA to control sympathetic output neurons in the DMH and rRPa, thereby performing bidirectional regulation of basal body temperature.[51] During infection, PGE2 produced in the brain inhibits the activity of EP3-expressing neurons in the POA to attenuate the inhibition of sympathetic output, and thereby activates the sympathetic output system, which evokes non-shivering thermogenesis to produce body heat and skin vasoconstriction to decrease heat loss from the body surface, leading to fever.[51] It is presumed that the innervation from the POA to the PVN mediates the neuroendocrine effects of fever through the pathway involving pituitary gland and various endocrine organs.
Diagnosis
[edit]| Temperature classification | ||||||||||||
|
||||||||||||
| Note: The difference between fever and hyperthermia is the underlying mechanism. Different sources have different cut-offs for fever, hyperthermia and hyperpyrexia. | ||||||||||||
A range for normal temperatures has been found.[8] Central temperatures, such as rectal temperatures, are more accurate than peripheral temperatures.[60] Fever is generally agreed to be present if the elevated temperature[61] is caused by a raised set point and:
- Temperature in the anus (rectum/rectal) is at or over 37.5–38.3 °C (99.5–100.9 °F).[1][8] An ear (tympanic) or forehead (temporal) temperature may also be used.[62][63]
- Temperature in the mouth (oral) is at or over 37.2 °C (99.0 °F) in the morning or over 37.7 °C (99.9 °F) in the afternoon[7][64]
- Temperature under the arm (axillary) is usually about 0.6 °C (1.1 °F) below core body temperature.[65]
In adults, the normal range of temperatures in healthy individuals is 36.32–37.76 °C (97.4–100.0 °F) (rectal), 35.76–37.52 °C (96.4–99.5 °F) (ear), 35.61–37.61 °C (96.1–99.7 °F) (urine), 35.73–37.41 °C (96.3–99.3 °F) (oral), and 35.01–36.93 °C (95.0–98.5 °F) (axillary), with no significant gender differences.[66]
Normal body temperatures vary depending on many factors, including age, sex, time of day, ambient temperature, activity level, and more.[67][68] Normal daily temperature variation has been described as 0.5 °C (0.9 °F).[7]: 4012 A raised temperature is not always a fever.[67] For example, the temperature rises in healthy people when they exercise, but this is not considered a fever, as the set point is normal.[67] On the other hand, a "normal" temperature may be a fever, if it is unusually high for that person; for example, medically frail elderly people have a decreased ability to generate body heat, so a "normal" temperature of 37.3 °C (99.1 °F) may represent a clinically significant fever.[67][69]
Associated conditions
[edit]Fever is a common symptom of many medical conditions:
- Infectious disease, e.g., COVID-19,[14] dengue, Ebola, gastroenteritis, HIV, influenza, Lyme disease, rocky mountain spotted fever, secondary syphilis, malaria, mononucleosis, as well as infections of the skin, e.g., abscesses and boils.[70][71][72][73][74][75]
- Immunological diseases, e.g., relapsing polychondritis,[76] autoimmune hepatitis, granulomatosis with polyangiitis, Horton disease, inflammatory bowel diseases, Kawasaki disease, lupus erythematosus, sarcoidosis, Still's disease, rheumatoid arthritis, lymphoproliferative disorders and psoriasis;[citation needed]
- Tissue destruction, as a result of cerebral bleeding, crush syndrome, hemolysis, infarction, rhabdomyolysis, surgery, etc.;[77][78]
- Cancers, particularly blood cancers such as leukemia and lymphomas;[79]
- Metabolic disorders, e.g., gout, and porphyria;[80] and[81]
- Inherited metabolic disorder, e.g., Fabry disease.[7]
Adult and pediatric manifestations for the same disease may differ; for instance, in COVID-19, one metastudy describes 92.8% of adults versus 43.9% of children presenting with fever.[14]
In addition, fever can result from a reaction to an incompatible blood product.[82]
Types
[edit]
Various patterns of measured patient temperatures have been observed, some of which may be indicative of a particular medical diagnosis:
- Continuous fever, where temperature remains above normal and does not fluctuate more than 1 °C in 24 hours[83] (e.g. in bacterial pneumonia, typhoid fever, infective endocarditis, tuberculosis, or typhus).[84][85]
- Intermittent fever is present only for a certain period, later cycling back to normal (e.g., in malaria, leishmaniasis, pyemia, sepsis,[86] or African trypanosomiasis).[87]
- Remittent fever, where the temperature remains above normal throughout the day and fluctuates more than 1 °C in 24 hours (e.g., in infective endocarditis or brucellosis).[88]
- Pel–Ebstein fever is a cyclic fever that is rarely seen in patients with Hodgkin's lymphoma.[citation needed]
- Undulant fever, seen in brucellosis.[citation needed]
- Typhoid fever is a continuous fever showing a characteristic step-ladder pattern, a step-wise increase in temperature with a high plateau.[89]
Among the types of intermittent fever are ones specific to cases of malaria caused by different pathogens. These are:[90][91]
- Quotidian fever, with a 24-hour periodicity, typical of malaria caused by Plasmodium knowlesi (P. knowlesi);[92][93]
- Tertian fever, with a 48-hour periodicity, typical of later course malaria caused by P. falciparum, P. vivax, or P. ovale;[90]
- Quartan fever, with a 72-hour periodicity, typical of later course malaria caused by P. malariae.[90]
In addition, there is disagreement regarding whether a specific fever pattern is associated with Hodgkin's lymphoma—the Pel–Ebstein fever, with patients argued to present high temperature for one week, followed by low for the next week, and so on, where the generality of this pattern is debated.[94][95]
Persistent fever that cannot be explained after repeated routine clinical inquiries is called fever of unknown origin.[7][96] A neutropenic fever, also called febrile neutropenia, is a fever in the absence of normal immune system function.[97] Because of the lack of infection-fighting neutrophils, a bacterial infection can spread rapidly; this fever is, therefore, usually considered to require urgent medical attention.[98] This kind of fever is more commonly seen in people receiving immune-suppressing chemotherapy than in apparently healthy people.[97][99]
Hyperpyrexia
[edit]Hyperpyrexia is an extreme elevation of body temperature which, depending upon the source, is classified as a core body temperature greater than or equal to 40 or 41 °C (104 or 106 °F); the range of hyperpyrexia includes cases considered severe (≥ 40 °C) and extreme (≥ 42 °C).[7][100][101] It differs from hyperthermia in that one's thermoregulatory system's set point for body temperature is set above normal, then heat is generated to achieve it. In contrast, hyperthermia involves body temperature rising above its set point due to outside factors.[7][102] The high temperatures of hyperpyrexia are considered medical emergencies, as they may indicate a serious underlying condition or lead to severe morbidity (including permanent brain damage), or to death.[103] A common cause of hyperpyrexia is an intracranial hemorrhage.[7] Other causes in emergency room settings include Malignant Catatonia, sepsis, Kawasaki syndrome,[104] neuroleptic malignant syndrome, drug overdose, serotonin syndrome, and thyroid storm.[103]
Function
[edit]
Hypothermia: Characterized in the center: Normal body temperature is shown in green, while the hypothermic temperature is shown in blue. As can be seen, hypothermia can be conceptualized as a decrease below the thermoregulatory set point.
Fever: Characterized on the right: Normal body temperature is shown in green. It reads "New Normal" because the thermoregulatory set point has risen. This has caused what was the normal body temperature (in blue) to be considered hypothermic.
Immune function
[edit]Fever is thought to contribute to host defense,[17] as the reproduction of pathogens with strict temperature requirements can be hindered, and the rates of some important immunological reactions are increased by temperature.[105] Fever has been described in teaching texts as assisting the healing process in various ways, including:
- increased mobility of leukocytes;[106]: 1044
- enhanced leukocyte phagocytosis;[106]: 1030
- decreased endotoxin effects;[106]: 1029 and
- increased proliferation of T cells.[106]: 1030 [107]: 212
Advantages and disadvantages
[edit]A fever response to an infectious disease is generally regarded as protective, whereas fever in non-infections may be maladaptive.[108][109] Studies have not been consistent on whether treating fever generally worsens or improves mortality risk.[110] Benefits or harms may depend on the type of infection, health status of the patient and other factors.[108] Studies using warm-blooded vertebrates suggest that they recover more rapidly from infections or critical illness due to fever.[111] In sepsis, fever is associated with reduced mortality.[112][citation needed]
Management
[edit]Fever does not necessarily need to be treated,[113] and most people with a fever recover without specific medical attention.[114] Although it is unpleasant, fever rarely rises to a dangerous level even if untreated.[115] Damage to the brain generally does not occur until temperatures reach 40.0 °C (104.0 °F), and it is rare for an untreated fever to exceed 40.6 °C (105.1 °F).[116] Treating fever in people with sepsis does not affect outcomes.[117] Small trials have shown no benefit of treating fevers of 38.5 °C (101.3 °F) or higher of critically ill patients in ICUs, and one trial was terminated early because patients receiving aggressive fever treatment were dying more often.[19]
According to the NIH, the two assumptions which are generally used to argue in favor of treating fevers have not been experimentally validated. These are that (1) a fever is noxious, and (2) suppression of a fever will reduce its noxious effect. Most of the other studies supporting the association of fever with poorer outcomes have been observational in nature. In theory, these critically ill patients and those faced with additional physiologic stress may benefit from fever reduction, but the evidence on both sides of the argument appears to be mostly equivocal.[19]
Conservative measures
[edit]Limited evidence supports sponging or bathing feverish children with tepid water.[118] The use of a fan or air conditioning may somewhat reduce the temperature and increase comfort. If the temperature reaches the extremely high level of hyperpyrexia, aggressive cooling is required (generally produced mechanically via conduction by applying numerous ice packs across most of the body or direct submersion in ice water).[103] In general, people are advised to keep adequately hydrated.[119] Whether increased fluid intake improves symptoms or shortens respiratory illnesses such as the common cold is not known.[120]
Medications
[edit]Medications that lower fevers are called antipyretics.[121] The antipyretic ibuprofen is effective in reducing fevers in children.[122] It is more effective than acetaminophen (paracetamol) in children.[122] Ibuprofen and acetaminophen may safely be used together in children with fevers.[123][124] The efficacy of acetaminophen by itself in children with fevers has been questioned.[125] Ibuprofen is also superior to aspirin in children with fevers.[126] Additionally, aspirin is not recommended in children and young adults (those under the age of 16 or 19 depending on the country) due to the risk of Reye's syndrome.[127]
Using both paracetamol and ibuprofen at the same time or alternating between the two is more effective at decreasing fever than using only paracetamol or ibuprofen.[128] It is not clear if it increases child comfort.[128] Response or nonresponse to medications does not predict whether or not a child has a serious illness.[129]
With respect to the effect of antipyretics on the risk of death in those with infection, studies have found mixed results, as of 2019.[130]
Epidemiology
[edit]Fever is one of the most common medical signs.[2] It is part of about 30% of healthcare visits by children,[2] and occurs in up to 75% of adults who are seriously sick.[11] About 5% of people who go to an emergency room have a fever.[131]
History
[edit]A number of types of fever were known as early as 460 BC to 370 BC when Hippocrates was practicing medicine including that due to malaria (tertian or every 2 days and quartan or every 3 days).[132] It also became clear around this time that fever was a symptom of disease rather than a disease in and of itself.[132]
Infections presenting with fever were a major source of mortality in humans for about 200,000 years. Until the late nineteenth century, approximately half of all humans died from infections before the age of fifteen.[133]
An older term, febricula (a diminutive form of the Latin word for fever), was once used to refer to a low-grade fever lasting only a few days. This term fell out of use in the early 20th century, and the symptoms it referred to are now thought to have been caused mainly by various minor viral respiratory infections.[134]
Society and culture
[edit]Mythology
[edit]
- Febris (fever in Latin) is the goddess of fever in Roman mythology. People with fevers would visit her temples.
- Tertiana and Quartana are the goddesses of tertian and quartan fevers of malaria in Roman mythology.[135]
- Jvarasura (fever-demon in Hindi) is the personification of fever and disease in Hindu and Buddhist mythology.
Pediatrics
[edit]Fever is often viewed with greater concern by parents and healthcare professionals than might be deserved, a phenomenon known as fever phobia,[2][136] which is based in both caregiver's and parents' misconceptions about fever in children. Among them, many parents incorrectly believe that fever is a disease rather than a medical sign, that even low fevers are harmful, and that any temperature even briefly or slightly above the oversimplified "normal" number marked on a thermometer is a clinically significant fever.[136] They are also afraid of harmless side effects like febrile seizures and dramatically overestimate the likelihood of permanent damage from typical fevers.[136] The underlying problem, according to professor of pediatrics Barton D. Schmitt, is that "as parents we tend to suspect that our children's brains may melt."[137] As a result of these misconceptions parents are anxious, give the child fever-reducing medicine when the temperature is technically normal or only slightly elevated, and interfere with the child's sleep to give the child more medicine.[136]
Other animals
[edit]Fever is an important metric for the diagnosis of disease in domestic animals. The body temperature of animals, which is taken rectally, is different from one species to another. For example, a horse is said to have a fever above 101 °F (38.3 °C).[138] In species that allow the body to have a wide range of "normal" temperatures, such as camels,[139] whose body temperature varies as the environmental temperature varies,[140] the body temperature which constitutes a febrile state differs depending on the environmental temperature.[141] Fever can also be behaviorally induced by invertebrates that do not have immune-system based fever. For instance, some species of grasshopper will thermoregulate to achieve body temperatures that are 2–5 °C higher than normal in order to inhibit the growth of fungal pathogens such as Beauveria bassiana and Metarhizium acridum.[142] Honeybee colonies are also able to induce a fever in response to a fungal parasite Ascosphaera apis.[142]
References
[edit]- ^ a b c d e f g h i Axelrod YK, Diringer MN (May 2008). "Temperature management in acute neurologic disorders". Neurologic Clinics. 26 (2): 585–603, xi. doi:10.1016/j.ncl.2008.02.005. PMID 18514828.
- ^ a b c d e f g h i j k l Sullivan JE, Farrar HC (March 2011). "Fever and antipyretic use in children". Pediatrics. 127 (3): 580–587. doi:10.1542/peds.2010-3852. PMID 21357332.
- ^ a b c Huether, Sue E. (2014). Pathophysiology: The Biologic Basis for Disease in Adults and Children (7th ed.). Elsevier Health Sciences. p. 498. ISBN 978-0-323-29375-4.
- ^ a b CDC Staff (31 March 2020). "Taking Care of Someone Who is Sick: Caring for Someone Sick at Home". Archived from the original on 24 March 2015. Retrieved 8 May 2015.
- ^ a b Kluger MJ (2015). Fever: Its Biology, Evolution, and Function. Princeton University Press. p. 57. ISBN 978-1-4008-6983-1.
- ^ a b c Garmel GM, Mahadevan SV, eds. (2012). "Fever in adults". An introduction to clinical emergency medicine (2nd ed.). Cambridge: Cambridge University Press. p. 375. ISBN 978-0-521-74776-9.
- ^ a b c d e f g h i j k l m n o p Dinarello CA, Porat R (2018). "Chapter 15: Fever". In Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo, J (eds.). Harrison's Principles of Internal Medicine. Vol. 1–2 (20th ed.). New York: McGraw-Hill. ISBN 978-1-259-64403-0. Retrieved 31 March 2020.
- ^ a b c d e f Laupland KB (July 2009). "Fever in the critically ill medical patient". Critical Care Medicine. 37 (7 Suppl): S273-8. doi:10.1097/CCM.0b013e3181aa6117. PMID 19535958.
- ^ a b c d e Richardson M, Purssell E (September 2015). "Who's afraid of fever?". Archives of Disease in Childhood. 100 (9): 818–820. doi:10.1136/archdischild-2014-307483. PMID 25977564. S2CID 206857750.
- ^ a b Garmel GM, Mahadevan SV, eds. (2012). An introduction to clinical emergency medicine (2nd ed.). Cambridge: Cambridge University Press. p. 401. ISBN 978-0-521-74776-9.
- ^ a b c Kiekkas P, Aretha D, Bakalis N, Karpouhtsi I, Marneras C, Baltopoulos GI (August 2013). "Fever effects and treatment in critical care: literature review". Australian Critical Care. 26 (3): 130–135. doi:10.1016/j.aucc.2012.10.004. PMID 23199670.
- ^ Franjić, Siniša (31 March 2019). "Fever Can Be A Symptom of Many Diseases". Journal of Medicine and HealthCare: 1–3. doi:10.47363/jmhc/2021(3)146. S2CID 243837498.
- ^ a b c Garmel GM, Mahadevan SV, eds. (2012). An introduction to clinical emergency medicine (2nd ed.). Cambridge: Cambridge University Press. p. 5. ISBN 978-0-521-74776-9.
- ^ a b c Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C (13 March 2020). "Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis". Travel Medicine and Infectious Disease. 34 101623. doi:10.1016/j.tmaid.2020.101623. PMC 7102608. PMID 32179124.
- ^ Dayal R, Agarwal D (January 2016). "Fever in Children and Fever of Unknown Origin". Indian Journal of Pediatrics. 83 (1): 38–43. doi:10.1007/s12098-015-1724-4. PMID 25724501. S2CID 34481402.
- ^ "Fever". MedlinePlus. 30 August 2014. Archived from the original on 11 May 2009.
- ^ a b Schaffner A (March 2006). "Fieber – nützliches oder schädliches, zu behandelndes Symptom?" [Fever–useful or noxious symptom that should be treated?]. Therapeutische Umschau (in German). 63 (3): 185–188. doi:10.1024/0040-5930.63.3.185. PMID 16613288. Abstract alone is in German and in English.
- ^ Niven DJ, Stelfox HT, Laupland KB (June 2013). "Antipyretic therapy in febrile critically ill adults: A systematic review and meta-analysis". Journal of Critical Care. 28 (3): 303–310. doi:10.1016/j.jcrc.2012.09.009. PMID 23159136.
- ^ a b c Ray, Juliet J. (December 2015). "Fever: suppress or let it ride?". Journal of Thoracic Disease. 7 (12): E633 – E636. doi:10.3978/j.issn.2072-1439.2015.12.28. PMC 4703655. PMID 26793378.
- ^ Crocetti M, Moghbeli N, Serwint J (June 2001). "Fever Phobia Revisited: Have Parental Misconceptions About Fever Changed in 20 Years?". Pediatrics. 107 (6): 1241–1246. doi:10.1542/peds.107.6.1241. PMID 11389237.
- ^ "Fever: Symptoms, treatments, types, and causes". www.medicalnewstoday.com. 5 May 2020. Retrieved 22 April 2022.
- ^ Harden, L. M.; Kent, S.; Pittman, Q. J.; Roth, J. (1 November 2015). "Fever and sickness behavior: Friend or foe?". Brain, Behavior, and Immunity. 50: 322–333. doi:10.1016/j.bbi.2015.07.012. ISSN 0889-1591. PMID 26187566. S2CID 19396134.
- ^ Kelley KW, Bluthé RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR (February 2003). "Cytokine-induced sickness behavior". Brain, Behavior, and Immunity. 17 Suppl 1 (1): S112 – S118. doi:10.1016/S0889-1591(02)00077-6. PMID 12615196. S2CID 25400611.
- ^ Adamis D, Treloar A, Martin FC, Macdonald AJ (December 2007). "A brief review of the history of delirium as a mental disorder". History of Psychiatry. 18 (72 Pt 4): 459–469. doi:10.1177/0957154X07076467. hdl:2262/51619. PMID 18590023. S2CID 24424207.
- ^ Beard, Robin M.; Day, Michael W. (June 2008). "Fever and Hyperthermia". Nursing2022. 38 (6): 28–31. doi:10.1097/01.NURSE.0000320353.79079.a5. ISSN 0360-4039. PMID 18497656.
- ^ Ushikubi F, et al. (September 1998). "Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3". Nature. 395 (6699): 281–284. Bibcode:1998Natur.395..281U. doi:10.1038/26233. PMID 9751056. S2CID 4420632.
- ^ Evans SS, Repasky EA, Fisher DT (June 2015). "Fever and the thermal regulation of immunity: the immune system feels the heat". Nature Reviews. Immunology. 15 (6): 335–349. doi:10.1038/nri3843. PMC 4786079. PMID 25976513.
- ^ Nakamura, Kazuhiro (November 2011). "Central circuitries for body temperature regulation and fever". American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 301 (5): R1207 – R1228. doi:10.1152/ajpregu.00109.2011. ISSN 0363-6119. PMID 21900642.
- ^ Morrison, S.F.; Nakamura, K. (10 February 2019). "Central Mechanisms for Thermoregulation". Annual Review of Physiology. 81 (1): 285–308. doi:10.1146/annurev-physiol-020518-114546. ISSN 0066-4278. PMID 30256726.
- ^ Nakamura, Kazuhiro; Nakamura, Yoshiko; Kataoka, Naoya (January 2022). "A hypothalamomedullary network for physiological responses to environmental stresses". Nature Reviews Neuroscience. 23 (1): 35–52. doi:10.1038/s41583-021-00532-x. ISSN 1471-003X. PMID 34728833.
- ^ Nowack, Julia; Giroud, Sylvain; Arnold, Walter; Ruf, Thomas (9 November 2017). "Muscle Non-shivering Thermogenesis and Its Role in the Evolution of Endothermy". Frontiers in Physiology. 8: 889. doi:10.3389/fphys.2017.00889. ISSN 1664-042X. PMC 5684175. PMID 29170642.
- ^ Deussen, A. (September 2007). "[Hyperthermia and hypothermia. Effects on the cardiovascular system]". Der Anaesthesist. 56 (9): 907–911. doi:10.1007/s00101-007-1219-4. ISSN 0003-2417. PMID 17554514.
- ^ Hagel L, Jagschies G, Sofer G (1 January 2008). "5 – Analysis". Handbook of Process Chromatography (2nd ed.). Academic Press. pp. 127–145. doi:10.1016/b978-012374023-6.50007-5. ISBN 978-0-12-374023-6.
- ^ Kojima K (1 January 2012). "17 – Biological evaluation and regulation of medical devices in Japan". In Boutrand JP (ed.). Biocompatibility and Performance of Medical Devices. Woodhead Publishing Series in Biomaterials. Woodhead Publishing. pp. 404–448. doi:10.1533/9780857096456.4.404. ISBN 978-0-85709-070-6. S2CID 107630997.
- ^ El-Radhi, A. Sahib (2018), El-Radhi, A. Sahib (ed.), "Pathogenesis of Fever", Clinical Manual of Fever in Children, Cham: Springer International Publishing: 53–68, doi:10.1007/978-3-319-92336-9_3, ISBN 978-3-319-92336-9, PMC 7122269
- ^ Affairs, Office of Regulatory (3 November 2018). "Pyrogens, Still a Danger". FDA. Archived from the original on 2 May 2019.
- ^ Constable PD, Hinchcliff KW, Done SH, Grünberg W, eds. (1 January 2017). "4 – General Systemic States". Veterinary Medicine (11th ed.). W.B. Saunders. pp. 43–112. doi:10.1016/b978-0-7020-5246-0.00004-8. ISBN 978-0-7020-5246-0. PMC 7195945. S2CID 214758182.
- ^ Dinarello CA (31 March 2015). "The history of fever, leukocytic pyrogen and interleukin-1". Temperature. 2 (1): 8–16. doi:10.1080/23328940.2015.1017086. PMC 4843879. PMID 27226996.
- ^ a b Stitt, John (2008). "Chapter 59: Regulation of Body Temperature". In Boron WF, Boulpaep, EL (eds.). Medical Physiology: A Cellular and Molecular Approach (2nd ed.). Philadelphia: Elsevier Saunders. ISBN 978-1-4160-3115-4. Retrieved 2 April 2020.
- ^ Murphy, Kenneth (Kenneth M.) (2017). Janeway's immunobiology. Weaver, Casey (9th ed.). New York. pp. 118–119. ISBN 978-0-8153-4505-3. OCLC 933586700.
{{cite book}}: CS1 maint: location missing publisher (link) - ^ Stefferl A, Hopkins SJ, Rothwell NJ, Luheshi GN (August 1996). "The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat". British Journal of Pharmacology. 118 (8): 1919–1924. doi:10.1111/j.1476-5381.1996.tb15625.x. PMC 1909906. PMID 8864524.
- ^ Kennedy, Rachel H.; Silver, Rae (2016), Pfaff, Donald W.; Volkow, Nora D. (eds.), "Neuroimmune Signaling: Cytokines and the CNS", Neuroscience in the 21st Century, New York: Springer, pp. 1–41, doi:10.1007/978-1-4614-6434-1_174-1, ISBN 978-1-4614-6434-1
- ^ Eskilsson, Anna (2020). Inflammatory Signaling Across the Blood-Brain Barrier and the Generation of Fever. Linköping: Linköping University, Department of Biomedical and Clinical Sciences. ISBN 978-91-7929-936-1.
- ^ Srinivasan L, Harris MC, Kilpatrick LE (1 January 2017). "128 – Cytokines and Inflammatory Response in the Fetus and Neonate". In Polin RA, Abman SH, Rowitch DH, Benitz WE (eds.). Fetal and Neonatal Physiology (5th ed.). Elsevier. pp. 1241–1254.e4. doi:10.1016/b978-0-323-35214-7.00128-1. ISBN 978-0-323-35214-7.
- ^ Wilson ME, Boggild AK (1 January 2011). "130 – Fever and Systemic Symptoms". In Guerrant RL, Walker DH, Weller PF (eds.). Tropical Infectious Diseases: Principles, Pathogens and Practice (3rd ed.). W.B. Saunders. pp. 925–938. doi:10.1016/b978-0-7020-3935-5.00130-0. ISBN 978-0-7020-3935-5.
- ^ Roth J, Blatteis CM (October 2014). "Mechanisms of fever production and lysis: Lessons from experimental LPS fever". Comprehensive Physiology. 4 (4): 1563–1604. doi:10.1002/cphy.c130033. ISBN 978-0-470-65071-4. PMID 25428854.
- ^ Samuelsson, Bengt; Morgenstern, Ralf; Jakobsson, Per-Johan (September 2007). "Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target". Pharmacological Reviews. 59 (3): 207–224. doi:10.1124/pr.59.3.1. PMID 17878511.
- ^ Nakamura, Kazuhiro; Kaneko, Takeshi; Yamashita, Yoko; Hasegawa, Hiroshi; Katoh, Hironori; Ichikawa, Atsushi; Negishi, Manabu (29 January 1999). "Immunocytochemical localization of prostaglandin EP3 receptor in the rat hypothalamus". Neuroscience Letters. 260 (2): 117–120. doi:10.1016/S0304-3940(98)00962-8. PMID 10025713.
- ^ a b Nakamura, Kazuhiro; Matsumura, Kiyoshi; Kaneko, Takeshi; Kobayashi, Shigeo; Katoh, Hironori; Negishi, Manabu (1 June 2002). "The Rostral Raphe Pallidus Nucleus Mediates Pyrogenic Transmission from the Preoptic Area". The Journal of Neuroscience. 22 (11): 4600–4610. doi:10.1523/JNEUROSCI.22-11-04600.2002. ISSN 0270-6474. PMC 6758794. PMID 12040067.
- ^ Lazarus, Michael; Yoshida, Kyoko; Coppari, Roberto; Bass, Caroline E; Mochizuki, Takatoshi; Lowell, Bradford B; Saper, Clifford B (September 2007). "EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses". Nature Neuroscience. 10 (9): 1131–1133. doi:10.1038/nn1949. ISSN 1097-6256. PMID 17676060.
- ^ a b c Nakamura, Yoshiko; Yahiro, Takaki; Fukushima, Akihiro; Kataoka, Naoya; Hioki, Hiroyuki; Nakamura, Kazuhiro (23 December 2022). "Prostaglandin EP3 receptor–expressing preoptic neurons bidirectionally control body temperature via tonic GABAergic signaling". Science Advances. 8 (51) eadd5463. Bibcode:2022SciA....8D5463N. doi:10.1126/sciadv.add5463. ISSN 2375-2548. PMC 9788766. PMID 36563142.
- ^ Nakamura, Yoshiko; Nakamura, Kazuhiro; Matsumura, Kiyoshi; Kobayashi, Shigeo; Kaneko, Takeshi; Morrison, Shaun F. (December 2005). "Direct pyrogenic input from prostaglandin EP3 receptor-expressing preoptic neurons to the dorsomedial hypothalamus". European Journal of Neuroscience. 22 (12): 3137–3146. doi:10.1111/j.1460-9568.2005.04515.x. ISSN 0953-816X. PMC 2441892. PMID 16367780.
- ^ a b Nakamura, Y.; Nakamura, K.; Morrison, S.F. (30 June 2009). "Different populations of prostaglandin EP3 receptor-expressing preoptic neurons project to two fever-mediating sympathoexcitatory brain regions". Neuroscience. 161 (2): 614–620. doi:10.1016/j.neuroscience.2009.03.041. PMC 2857774. PMID 19327390.
- ^ Zhang, Zhi-Hua; Yu, Yang; Wei, Shun-Guang; Nakamura, Yoshiko; Nakamura, Kazuhiro; Felder, Robert B. (October 2011). "EP3 receptors mediate PGE2-induced hypothalamic paraventricular nucleus excitation and sympathetic activation". American Journal of Physiology. Heart and Circulatory Physiology. 301 (4): H1559 – H1569. doi:10.1152/ajpheart.00262.2011. ISSN 0363-6135. PMC 3197370. PMID 21803943.
- ^ Marx J (2006). Rosen's emergency medicine : concepts and clinical practice (6th ed.). Philadelphia: Mosby/Elsevier. p. 2239. ISBN 978-0-323-02845-5. OCLC 58533794.
- ^ Hutchison JS, Ward RE, Lacroix J, Hébert PC, Barnes MA, Bohn DJ, et al. (June 2008). "Hypothermia therapy after traumatic brain injury in children". The New England Journal of Medicine. 358 (23): 2447–56. doi:10.1056/NEJMoa0706930. PMID 18525042.
- ^ Pryor JA, Prasad AS (2008). Physiotherapy for Respiratory and Cardiac Problems: Adults and Paediatrics. Elsevier Health Sciences. p. 8. ISBN 978-0702039744.
Body temperature is maintained within the range 36.5-37.5 °C. It is lowest in the early morning and highest in the afternoon.
- ^ Grunau BE, Wiens MO, Brubacher JR (September 2010). "Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review". Cjem. 12 (5): 435–42. doi:10.1017/s1481803500012598. PMID 20880437.
Dantrolene may also be associated with improved survival and reduced complications, especially in patients with extreme (≥ 42 °C) or severe (≥ 40 °C) hyperpyrexia
- ^ Sharma HS, ed. (2007). Neurobiology of Hyperthermia (1st ed.). Elsevier. pp. 175–177, 485. ISBN 9780080549996. Retrieved 19 November 2016.
Despite the myriad of complications associated with heat illness, an elevation of core temperature above 41.0 °C (often referred to as fever or hyperpyrexia) is the most widely recognized symptom of this syndrome.
- ^ Niven DJ, Gaudet JE, Laupland KB, Mrklas KJ, Roberts DJ, Stelfox HT (November 2015). "Accuracy of peripheral thermometers for estimating temperature: a systematic review and meta-analysis". Annals of Internal Medicine. 163 (10): 768–777. doi:10.7326/M15-1150. PMID 26571241. S2CID 4004360.
- ^ "Fever - Symptoms and causes". Mayo Clinic. Retrieved 23 April 2022.
- ^ "Measuring a Baby's Temperature". www.hopkinsmedicine.org. Archived from the original on 3 November 2019. Retrieved 10 September 2019.
- ^ "Tips for taking your child's temperature". Mayo Clinic. Retrieved 10 September 2019.
- ^ Barone JE (August 2009). "Fever: Fact and fiction". The Journal of Trauma. 67 (2): 406–409. doi:10.1097/TA.0b013e3181a5f335. PMID 19667898.
- ^ Pecoraro, Valentina; Petri, Davide; Costantino, Giorgio; Squizzato, Alessandro; Moja, Lorenzo; Virgili, Gianni; Lucenteforte, Ersilia (25 November 2020). "The diagnostic accuracy of digital, infrared and mercury-in-glass thermometers in measuring body temperature: a systematic review and network meta-analysis". Internal and Emergency Medicine. 16 (4). Springer Science and Business Media LLC: 1071–1083. doi:10.1007/s11739-020-02556-0. ISSN 1828-0447. PMC 7686821. PMID 33237494.
- ^ Geneva, Ivayla I.; Cuzzo, Brian; Fazili, Tasaduq; Javaid, Waleed (2019). "Normal Body Temperature: A Systematic Review". Open Forum Infectious Diseases. 6 (4) ofz032. doi:10.1093/ofid/ofz032. PMC 6456186. PMID 30976605.
- ^ a b c d Garami, András; Székely, Miklós (6 May 2014). "Body temperature". Temperature: Multidisciplinary Biomedical Journal. 1 (1): 28–29. doi:10.4161/temp.29060. ISSN 2332-8940. PMC 4972507. PMID 27583277.
- ^ "Body temperature: What is the new normal?". www.medicalnewstoday.com. 12 January 2020. Retrieved 7 April 2020.
- ^ Alsalamah, M; Alrehaili, B; Almoamary, A; Al-Juad, A; Badri, M; El-Metwally, A (July 2022). "The optimal oral body temperature cutoff and other factors predictive of sepsis diagnosis in elderly patients". Annals of Thoracic Medicine. 17 (3): 159–165. doi:10.4103/atm.atm_52_22. PMC 9374123. PMID 35968398.
- ^ Raoult, Didier; Levy, Pierre-Yves; Dupont, Hervé Tissot; Chicheportiche, Colette; Tamalet, Catherine; Gastaut, Jean-Albert; Salducci, Jacques (January 1993). "Q fever and HIV infection". AIDS. 7 (1): 81–86. doi:10.1097/00002030-199301000-00012. ISSN 0269-9370. PMID 8442921.
- ^ French, Neil; Nakiyingi, Jessica; Lugada, Eric; Watera, Christine; Whitworth, James A. G.; Gilks, Charles F. (May 2001). "Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults". AIDS. 15 (7): 899–906. doi:10.1097/00002030-200105040-00010. ISSN 0269-9370. PMID 11399962. S2CID 25470703. Archived from the original on 22 February 2022.
- ^ Heymann, D. L.; Weisfeld, J. S.; Webb, P. A.; Johnson, K. M.; Cairns, T.; Berquist, H. (1 September 1980). "Ebola Hemorrhagic Fever: Tandala, Zaire, 1977–1978". Journal of Infectious Diseases. 142 (3): 372–376. doi:10.1093/infdis/142.3.372. ISSN 0022-1899. PMID 7441008.
- ^ Feldmann, Heinz; Geisbert, Thomas W (March 2011). "Ebola haemorrhagic fever". The Lancet. 377 (9768): 849–862. doi:10.1016/s0140-6736(10)60667-8. ISSN 0140-6736. PMC 3406178. PMID 21084112.
- ^ Oakley, Miranda S.; Gerald, Noel; McCutchan, Thomas F.; Aravind, L.; Kumar, Sanjai (October 2011). "Clinical and molecular aspects of malaria fever". Trends in Parasitology. 27 (10): 442–449. doi:10.1016/j.pt.2011.06.004. ISSN 1471-4922. PMID 21795115.
- ^ Colunga-Salas, Pablo; Sánchez-Montes, Sokani; Volkow, Patricia; Ruíz-Remigio, Adriana; Becker, Ingeborg (17 September 2020). "Lyme disease and relapsing fever in Mexico: An overview of human and wildlife infections". PLOS ONE. 15 (9) e0238496. Bibcode:2020PLoSO..1538496C. doi:10.1371/journal.pone.0238496. ISSN 1932-6203. PMC 7497999. PMID 32941463.
- ^ Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C (March 2014). "Relapsing polychondritis". Joint, Bone, Spine. 81 (2): 118–124. doi:10.1016/j.jbspin.2014.01.001. PMID 24556284. S2CID 205754989.
- ^ Arnhold, Jürgen (2020). "Cell and Tissue Destruction in Selected Disorders". Cell and Tissue Destruction. Elsevier. pp. 249–287. doi:10.1016/b978-0-12-816388-7.00009-7. ISBN 978-0-12-816388-7. S2CID 209284148.
- ^ Arnhold, Jürgen (2019). Cell and tissue destruction: mechanisms, protection, disorders. Elsevier Science. ISBN 978-0-12-816388-7. OCLC 1120070914.
- ^ "Signs and Symptoms of Cancer | Do I Have Cancer?". www.cancer.org. Retrieved 20 June 2020.
- ^ Centerwall, Willard R. (1965). Phenylketonuria: an inherited metabolic disorder associated with mental retardation. U.S. Department of Health, Education, and Welfare, Welfare Administration, Children's Bureau. OCLC 392284.
- ^ "Metabolic Disorder". Definitions. Qeios. 7 February 2020. doi:10.32388/7344b1. S2CID 42063856.
- ^ Dean, Laura (2005). Blood transfusions and the immune system. National Center for Biotechnology Information (US).
- ^ Ogoina D (August 2011). "Fever, fever patterns and diseases called 'fever' – a review". Journal of Infection and Public Health. 4 (3): 108–124. doi:10.1016/j.jiph.2011.05.002. PMID 21843857.
- ^ Typhoid fever may show a specific fever pattern, with a slow stepwise increase and a high plateau (drops due to fever-reducing drugs are excluded).[citation needed]
- ^ Dall, Lawrence; Stanford, James F. (1990). "Fever, Chills, and Night Sweats". In Walker, H. Kenneth; Hall, W. Dallas; Hurst, J. Willis (eds.). Clinical Methods: The History, Physical, and Laboratory Examinations (3rd ed.). Boston: Butterworths. ISBN 0-409-90077-X. PMID 21250166.
- ^ Inayatullah, Muhammad; Nasir, Shabbir Ahmed (2016). Bedside Techniques: Methods of Clinical Examination (4th ed.). Paramount Books (Pvt.) Limited. ISBN 978-969-494-920-8.[page needed]
- ^ "African Trypanosomiasis – Disease". CDC. 28 April 2020. Archived from the original on 18 July 2021. Retrieved 18 July 2021.
- ^ "Brucella/Brucellosis". The Lecturio Medical Concept Library. Retrieved 19 July 2021.
- ^ "Enteric Fever (Typhoid Fever)". The Lecturio Medical Concept Library. 27 August 2020. Retrieved 19 July 2021.
- ^ a b c Ferri FF (2009). "Chapter 332. Protozoal infections". Ferri's Color Atlas and Text of Clinical Medicine. Elsevier Health Sciences. pp. 1159ff. ISBN 978-1-4160-4919-7. Archived from the original on 3 June 2016. Retrieved 31 March 2020.
- ^ Muhammad I, Nasir, SA (2009). Bedside Techniques: Methods of Clinical Examination. Multan, Pakistan: Saira Publishers/Salamat Iqbal Press.[page needed][better source needed]
- ^ Singh, B.; Daneshvar, C. (1 April 2013). "Human Infections and Detection of Plasmodium knowlesi". Clinical Microbiology Reviews. 26 (2): 165–184. doi:10.1128/CMR.00079-12. PMC 3623376. PMID 23554413.
- ^ Chin, W.; Contacos, P. G.; Coatney, G. R.; Kimball, H. R. (20 August 1965). "A Naturally Acquired Quotidian-Type Malaria in Man Transferable to Monkeys". Science. 149 (3686): 865. Bibcode:1965Sci...149..865C. doi:10.1126/science.149.3686.865. PMID 14332847. S2CID 27841173.
- ^ "Hodgkin Lymphoma: Practice Essentials, Background, Pathophysiology". Medscape. 9 November 2021.
- ^ Hilson AJ (July 1995). "Pel-Ebstein fever". The New England Journal of Medicine. 333 (1): 66–67. doi:10.1056/NEJM199507063330118. PMID 7777006., which cites Richard Asher's lecture, "Making Sense" [Lancet (1959) 2: 359].
- ^ Magrath, Melissa; Pearlman, Michelle; Peng, Lan; Lee, William (30 June 2018). "Granulomatous Hepatitis and Persistent Fever of Unknown Origin: A Case Report". Gastroenterology, Hepatology & Digestive Disorders. 1 (2): 1–2. doi:10.33425/2639-9334.1009. ISSN 2639-9334. S2CID 86786427.
- ^ a b Klastersky, Jean A. (2014), "Prevention of Febrile Neutropenia", Febrile Neutropenia, Tarporley: Springer Healthcare Ltd., pp. 13–26, doi:10.1007/978-1-907673-70-2_2, ISBN 978-1-907673-69-6
- ^ White, Lindsey; Ybarra, Michael (1 December 2017). "Neutropenic Fever". Hematology/Oncology Clinics of North America. 31 (6): 981–993. doi:10.1016/j.hoc.2017.08.004. PMID 29078933 – via ClinicalKey.
- ^ Rolston, Kenneth VI; Rubenstein, Edward B., eds. (2001). Textbook of febrile neutropenia. Martin Dunitz. ISBN 978-1-84184-033-8. OCLC 48195937.
- ^ Grunau BE, Wiens MO, Brubacher JR (September 2010). "Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review". Canadian Journal of Emergency Medicine. 12 (5): 435–442. doi:10.1017/s1481803500012598. PMID 20880437.
Dantrolene may also be associated with improved survival and reduced complications, especially in patients with extreme (≥ 42 °C) or severe (≥ 40 °C) hyperpyrexia
- ^ Sharma HS, ed. (2007). Neurobiology of Hyperthermia (1st ed.). Elsevier. pp. 175–177, 485. ISBN 978-0-08-054999-6. Archived from the original on 8 September 2017. Retrieved 19 November 2016.
Despite the myriad of complications associated with heat illness, an elevation of core temperature above 41.0 °C (often referred to as fever or hyperpyrexia) is the most widely recognized symptom of this syndrome.
- ^ See section in Chapter 15 therein, the section on "Fever versus hyperthermia".
- ^ a b c McGugan EA (March 2001). "Hyperpyrexia in the emergency department". Emergency Medicine. 13 (1): 116–120. doi:10.1046/j.1442-2026.2001.00189.x. PMID 11476402.
- ^ Marx (2006), p. 2506.
- ^ Fischler MP, Reinhart WH (May 1997). "[Fever: friend or enemy?]". Schweizerische Medizinische Wochenschrift (in German). 127 (20): 864–870. PMID 9289813.
- ^ a b c d Craven RF, Hirnle CJ (2003). Fundamentals of Nursing: Human Health and Function (4th ed.). Philadelphia, PA: Lippincott Williams & Wilkins. ISBN 978-0-7817-5818-5. Retrieved 2 April 2020.
- ^ Lewis SM, Dirksen SR, Heitkemper MM (2005). Medical-Surgical Nursing: Assessment and Management of Clinical Problems (6th ed.). Amsterdam, NL: Elsevier-Health Sciences. ISBN 978-0-323-03105-9. Retrieved 2 April 2020.
- ^ a b Kiekkas P, Aretha D, Bakalis N, Karpouhtsi I, Marneras C, Baltopoulos GI (August 2013). "Fever effects and treatment in critical care: literature review". Australian Critical Care. 26 (3): 130–135. doi:10.1016/j.aucc.2012.10.004. PMID 23199670.
- ^ Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D (September 1998). "Role of fever in disease". Annals of the New York Academy of Sciences. 856 (1): 224–233. Bibcode:1998NYASA.856..224K. doi:10.1111/j.1749-6632.1998.tb08329.x. PMID 9917881. S2CID 12408561.
- ^ Drewry, Anne M.; Ablordeppey, Enyo A.; Murray, Ellen T.; Stoll, Carolyn R. T.; Izadi, Sonya R.; Dalton, Catherine M.; Hardi, Angela C.; Fowler, Susan A.; Fuller, Brian M.; Colditz, Graham A. (2017). "Antipyretic Therapy in Critically Ill Septic Patients". Critical Care Medicine. 45 (5): 806–813. doi:10.1097/CCM.0000000000002285. PMC 5389594. PMID 28221185.
- ^ Su F, Nguyen ND, Wang Z, Cai Y, Rogiers P, Vincent JL (June 2005). "Fever control in septic shock: beneficial or harmful?". Shock. 23 (6): 516–520. PMID 15897803.
- ^ Rumbus, Z; Matics, R; Hegyi, P; et al. (2017). "Fever Is Associated with Reduced, Hypothermia with Increased Mortality in Septic Patients: A Meta-Analysis of Clinical Trials". PLOS ONE. 12 (1) e0170152. Bibcode:2017PLoSO..1270152R. doi:10.1371/journal.pone.0170152. PMC 5230786. PMID 28081244.
- ^ Ludwig J, McWhinnie H (May 2019). "Antipyretic drugs in patients with fever and infection: literature review". Br J Nurs. 28 (10): 610–618. doi:10.12968/bjon.2019.28.10.610. PMID 31116598. S2CID 162182092.
- ^ "What To Do If You Get Sick: 2009 H1N1 and Seasonal Flu". Centers for Disease Control and Prevention. 7 May 2009. Archived from the original on 3 November 2009. Retrieved 1 November 2009.
- ^ Klein, Natalie C.; Cunha, Burke A. (1 March 1996). "Treatment of Fever". Infectious Disease Clinics of North America. 10 (1): 211–216. doi:10.1016/S0891-5520(05)70295-6. ISSN 0891-5520. PMID 8698992.
- ^ Edward James Walter; Mike Carraretto (2016). "The neurological and cognitive consequences of hyperthermia". Critical Care. 20 (1): 199. doi:10.1186/s13054-016-1376-4. PMC 4944502. PMID 27411704.
- ^ Drewry AM, Ablordeppey EA, Murray ET, Stoll CR, Izadi SR, Dalton CM, Hardi AC, Fowler SA, Fuller BM, Colditz GA (May 2017). "Antipyretic Therapy in Critically Ill Septic Patients: A Systematic Review and Meta-Analysis". Critical Care Medicine. 45 (5): 806–813. doi:10.1097/CCM.0000000000002285. PMC 5389594. PMID 28221185.
- ^ Meremikwu M, Oyo-Ita A (2003). Meremikwu MM (ed.). "Physical methods for treating fever in children". The Cochrane Database of Systematic Reviews. 2003 (2) CD004264. doi:10.1002/14651858.CD004264. PMC 6532675. PMID 12804512.
- ^ "Fever". National Institute of Health. Archived from the original on 30 April 2016.
- ^ Guppy MP, Mickan SM, Del Mar CB, Thorning S, Rack A (February 2011). "Advising patients to increase fluid intake for treating acute respiratory infections". The Cochrane Database of Systematic Reviews. 2011 (2) CD004419. doi:10.1002/14651858.CD004419.pub3. PMC 7197045. PMID 21328268.
- ^ El-Radhi, A. S. (1 October 2000). "Physical treatment of fever". Archives of Disease in Childhood. 83 (4): 369c–369. doi:10.1136/adc.83.4.369c. ISSN 0003-9888. PMC 1718494. PMID 11032580.
- ^ a b Perrott DA, Piira T, Goodenough B, Champion GD (June 2004). "Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis". Archives of Pediatrics & Adolescent Medicine. 158 (6): 521–526. doi:10.1001/archpedi.158.6.521. PMID 15184213.
- ^ Hay AD, Redmond NM, Costelloe C, Montgomery AA, Fletcher M, Hollinghurst S, Peters TJ (May 2009). "Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial". Health Technology Assessment. 13 (27): iii–iv, ix–x, 1–163. doi:10.3310/hta13270. hdl:10044/1/57595. PMID 19454182.
- ^ Southey ER, Soares-Weiser K, Kleijnen J (September 2009). "Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever". Current Medical Research and Opinion. 25 (9): 2207–2222. doi:10.1185/03007990903116255. PMID 19606950. S2CID 31653539.
- ^ Meremikwu M, Oyo-Ita A (2002). "Paracetamol for treating fever in children". The Cochrane Database of Systematic Reviews. 2002 (2) CD003676. doi:10.1002/14651858.CD003676. PMC 6532671. PMID 12076499.
- ^ Autret E, Reboul-Marty J, Henry-Launois B, Laborde C, Courcier S, Goehrs JM, Languillat G, Launois R (1997). "Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever". European Journal of Clinical Pharmacology. 51 (5): 367–371. doi:10.1007/s002280050215. PMID 9049576. S2CID 27519225.
- ^ "2.9 Antiplatelet drugs". British National Formulary for Children. British Medical Association and Royal Pharmaceutical Society of Great Britain. 2007. p. 151.
- ^ a b Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW (October 2013). "Combined and alternating paracetamol and ibuprofen therapy for febrile children". The Cochrane Database of Systematic Reviews. 2013 (10) CD009572. doi:10.1002/14651858.CD009572.pub2. PMC 6532735. PMID 24174375.
- ^ King D (August 2013). "Question 2: does a failure to respond to antipyretics predict serious illness in children with a fever?". Archives of Disease in Childhood. 98 (8): 644–646. doi:10.1136/archdischild-2013-304497. PMID 23846358. S2CID 32438262.
- ^ Ludwig J, McWhinnie H (May 2019). "Antipyretic drugs in patients with fever and infection: literature review". British Journal of Nursing. 28 (10): 610–618. doi:10.12968/bjon.2019.28.10.610. PMID 31116598. S2CID 162182092.
- ^ Nassisi D, Oishi ML (January 2012). "Evidence-based guidelines for evaluation and antimicrobial therapy for common emergency department infections". Emergency Medicine Practice. 14 (1): 1–28, quiz 28–29. PMID 22292348.
- ^ a b Sajadi MM, Bonabi R, Sajadi MR, Mackowiak PA (October 2012). "Akhawayni and the first fever curve". Clinical Infectious Diseases. 55 (7): 976–980. doi:10.1093/cid/cis596. PMID 22820543.
- ^ Casanova, Jean-Laurent; Abel, Laurent (2021). "Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories". Annual Review of Pathology: Mechanisms of Disease. 16: 23–50. doi:10.1146/annurev-pathol-031920-101429. PMC 7923385. PMID 32289233.
- ^ Straus, Bernard (September 1970) [first presented at a conference on 27 May 1970]. "Defunct and Dying Diseases". Bulletin of the New York Academy of Medicine. 46 (9): 686–706. PMC 1749762. PMID 4916301.
- ^ Scheid, John (22 December 2015), "Febris", Oxford Research Encyclopedia of Classics, Oxford University Press, doi:10.1093/acrefore/9780199381135.013.2651, ISBN 978-0-19-938113-5, retrieved 23 January 2023
- ^ a b c d Crocetti M, Moghbeli N, Serwint J (June 2001). "Fever Phobia Revisited: Have Parental Misconceptions About Fever Changed in 20 Years?". Pediatrics. 107 (6): 1241–1246. doi:10.1542/peds.107.6.1241. PMID 11389237. Retrieved 31 March 2020.
- ^ Klass, Perri (10 January 2011). "Lifting a Veil of Fear to See a Few Benefits of Fever". The New York Times. Archived from the original on 29 September 2015.
- ^ "Equusite Vital Signs". equusite.com. Archived from the original on 26 March 2010. Retrieved 22 March 2010.
- ^ Schmidt-Nielsen K, Schmidt-Nielsen B, Jarnum SA, Houpt TR (January 1957). "Body temperature of the camel and its relation to water economy". The American Journal of Physiology. 188 (1): 103–112. doi:10.1152/ajplegacy.1956.188.1.103. PMID 13402948.
- ^ Leese A (March 1917). "'Tips' on camels, for veterinary surgeons on active service". The British Veterinary Journal. 73: 81 – via Google Books.
- ^ Tefera M (July 2004). "Observations on the clinical examination of the camel (Camelus dromedarius) in the field". Tropical Animal Health and Production. 36 (5): 435–449. doi:10.1023/b:trop.0000035006.37928.cf. PMID 15449833. S2CID 26358556.
- ^ a b Thomas MB, Blanford S (July 2003). "Thermal biology in insect-parasite interactions". Trends in Ecology & Evolution. 18 (7): 344–350. doi:10.1016/S0169-5347(03)00069-7.
Further reading
[edit]- Rhoades R, Pflanzer RG (1996). "Chapter 27: Regulation of Body Temperature (Clinical Focus: Pathogenesis of Fever)". Human Physiology (3rd ed.). Philadelphia: Saunders College. ISBN 978-0-03-005159-3. Retrieved 2 April 2020.
External links
[edit]- Fever and Taking Your Child's Temperature
- US National Institute of Health factsheet
- Drugs most commonly associated with the adverse event Pyrexia (Fever) as reported the FDA Archived 9 March 2012 at the Wayback Machine
- Fever at MedlinePlus
- Why are We So Afraid of Fevers? at The New York Times
Fever
View on GrokipediaIntroduction and Basics
Definition
Fever, also known as pyrexia, is defined as the elevation of an individual's core body temperature above a set-point regulated by the body's thermoregulatory center in the hypothalamus.[1] This elevation typically exceeds 38°C (100.4°F) orally or rectally, though precise thresholds can range from 37.5°C to 38.3°C (99.5°F to 100.9°F) depending on clinical context and measurement method.[9][10] The term "fever" derives from the Latin febris, meaning heat or a passionate state associated with burning or inflammation.[11] In contrast to normothermia, where core body temperature maintains within a normal range influenced by factors such as age, time of day, and measurement site, fever represents a pathological deviation driven by internal regulatory changes.[12] Normal temperature varies diurnally, lowest in the early morning and peaking in the late afternoon by up to 0.5°C (0.9°F), and differs by age—typically lower in older adults—and site: normal oral temperatures typically range from 36.1°C to 37.2°C (97°F to 99°F), rectal are 0.3–0.5°C higher, axillary 0.5–1.0°C lower, and tympanic approximates oral but with potential variability.[13][14][15] Physiologically, fever is a regulated process involving an upward adjustment of the hypothalamic set point, distinguishing it from unregulated conditions like hyperthermia where body temperature rises due to environmental overload or metabolic excess without central modulation.[1]Normal Body Temperature
The normal human core body temperature typically ranges from 36.1°C to 37.2°C (97°F to 99°F), with an average of 37°C (98.6°F).[16] This value represents the internal temperature maintained by the body's thermoregulatory mechanisms in healthy individuals under standard conditions.[13] Body temperature exhibits a diurnal variation, influenced by the circadian rhythm, with the lowest values occurring in the early morning (around 4–6 a.m.) and the highest in the late afternoon (around 4–6 p.m.), typically fluctuating by 0.25–0.5°C throughout the day.[13] Measurement sites yield different norms due to anatomical and physiological differences: rectal temperature is generally 0.27–0.38°C higher than oral, providing a closer approximation to core temperature, while axillary (armpit) readings are about 0.55°C lower than oral.[13] For instance, average values from systematic reviews indicate rectal at approximately 37.04°C, oral at 36.8°C, and axillary at around 36.3°C.[17] Several factors influence baseline body temperature. Infants and young children often have slightly higher averages (up to 37.5°C), while older adults may trend lower; sex differences show women averaging about 0.2–0.4°C higher than men, particularly during the luteal phase of the menstrual cycle.[18] Physical activity, such as exercise, can elevate temperature by 1–2°C temporarily due to increased metabolic heat production, and environmental factors like ambient heat can raise it further, though the body compensates through sweating and vasodilation.[13] Common methods for measuring body temperature include digital thermometers (for oral, rectal, or axillary use), infrared tympanic thermometers (ear-based), and non-contact infrared forehead or temporal artery thermometers. Digital thermometers are highly accurate (±0.1°C) when properly placed and are preferred for their reliability and ease of use compared to phased-out mercury glass models, which had similar precision but posed safety risks.[19] Infrared tympanic devices offer quick readings but can be less accurate (±0.2–0.5°C) if earwax obstructs the canal or the probe is not positioned correctly, while forehead models may overestimate or underestimate by up to 0.5°C in varying ambient conditions or with user movement.[20] Common errors across methods include recent ingestion of hot/cold fluids affecting oral readings, shallow insertion in rectal measurements leading to underestimation, or environmental interference (e.g., drafts) skewing infrared results.[19]Clinical Presentation
Symptoms
Fever typically manifests through a sequence of subjective and objective signs reflecting the body's thermoregulatory adjustments. In the initial phase, individuals often experience chills or rigors, characterized by shivering and involuntary muscle contractions as the body generates heat to reach the elevated hypothalamic set point.[1] Once the plateau temperature is attained, sensations of warmth and flushed skin predominate, accompanied by tachycardia that increases by approximately 10 beats per minute for each 1°C rise in core temperature.[13] As the fever resolves during defervescence, profuse sweating occurs to facilitate heat loss and return to baseline temperature.[2] Associated symptoms frequently accompany these core signs, enhancing the overall discomfort. Fatigue and malaise are among the most prevalent, reported in over 50% and approximately 47% of febrile episodes, respectively, often leading to generalized weakness.[21] Headache, myalgias (muscle aches), and anorexia (loss of appetite) are also common, affecting roughly 45-47% of cases, while irritability may contribute to restlessness.[2][21] Presentations vary by age group, influencing recognition and management. In infants, fever often appears as irritability, poor feeding, and lethargy rather than pronounced chills or sweating, potentially masking the condition.[22] Adults typically report more classic symptoms like lethargy and muscle aches, although in some viral infections—particularly mild cases, early stages, or certain respiratory viruses—fever may present as the primary or isolated symptom. This presentation is uncommon in adults compared to children, where fever without localizing signs is more frequent in viral illnesses, and isolated fever in adults may warrant further evaluation to exclude other causes such as bacterial infections.[4] Whereas the elderly exhibit a blunted response, with attenuated fever magnitude and fewer overt signs, increasing the risk of underdetection.[23] Prolonged fever exacerbates these effects, promoting dehydration through heightened insensible fluid losses and diminished oral intake, which in severe instances may induce confusion or altered mental status.[24]Complications
Fever, while often a beneficial immune response, can lead to short-term complications, particularly in children. One of the most common is febrile seizures, which occur in 2–5% of children aged 6 months to 5 years during febrile illnesses, typically those caused by viral infections.[25] These seizures are generally benign, with most children experiencing a full recovery and no long-term neurological sequelae, though they warrant prompt medical evaluation to rule out underlying serious infections.[26] Another short-term risk is dehydration, resulting from increased insensible fluid losses through the skin and respiratory tract, exacerbated by tachypnea and reduced oral intake during illness; this is especially pronounced in infants and young children, where fever can accelerate evaporative losses by up to 10–15% per degree Celsius rise above normal.[27] High-grade fevers of 104°F (40°C) or higher are considered serious and generally warrant prompt medical attention. There is no fixed safe duration, as it depends on age, overall health, and underlying cause. Fevers in the 101–104°F range from common viral infections are often not harmful and may last 2–3 days in otherwise healthy people. However, prolonged or untreated high fevers can cause complications such as dehydration, seizures (particularly febrile seizures in children), and organ stress. Immediate care is advised if accompanied by severe symptoms like confusion, stiff neck, or difficulty breathing.[2][28][29] In extreme cases of sustained hyperpyrexia, defined as core body temperature exceeding 41.5°C, fever constitutes a medical emergency. A sustained temperature of 42°C or higher risks brain damage, organ failure, and death if not rapidly corrected, in addition to neuronal damage from blood-brain barrier disruption and cerebral edema, multi-organ failure due to systemic inflammation and hypoperfusion, and rhabdomyolysis from muscle breakdown triggered by hypermetabolic states.[30][31][32] These complications arise when the body's thermoregulatory mechanisms fail, leading to cellular injury and potential irreversible organ dysfunction if not rapidly corrected.[33] Certain populations face heightened risks from fever. Neonates are particularly vulnerable to sepsis, as their immature immune systems and nonspecific fever responses can mask rapidly progressing bacterial infections, increasing mortality if untreated.[34] In immunocompromised individuals, such as those with HIV or undergoing chemotherapy, fever often signals disseminated infections that can worsen due to impaired pathogen clearance, leading to higher rates of bacteremia and septic shock.[35] Elderly patients experience added cardiovascular strain from fever-induced tachycardia and increased myocardial oxygen demand, which can precipitate arrhythmias or exacerbate underlying heart disease in those over 70 years.[36] Rare but severe outcomes include overlap with heat stroke in cases of uncontrolled hyperpyrexia, where environmental factors compound endogenous fever, resulting in mortality rates of 10–50% depending on the timeliness of cooling interventions and comorbidities.[37] Prompt antipyretic therapy and supportive care can mitigate these risks across all groups.Pathophysiology
Hypothalamic Regulation
The hypothalamus serves as the central thermoregulatory center of the body, with the preoptic area, particularly the ventral medial preoptic (VMPO) region, acting as the primary thermostat that maintains core temperature homeostasis. This area integrates afferent thermal signals from peripheral thermoreceptors in the skin and central sensors in the viscera, spinal cord, and hypothalamus itself, as well as humoral inputs from the bloodstream via circumventricular organs like the organum vasculosum of the lamina terminalis (OVLT), which lacks a blood-brain barrier. These inputs allow the hypothalamus to continuously monitor and compare actual body temperature against a defended set point, typically around 37°C in humans.[38] During fever, the hypothalamic set point is elevated through prostaglandin E2 (PGE2)-mediated alterations in the thermosensitive neurons of the preoptic area. Exogenous or endogenous pyrogens induce the expression of cyclooxygenase-2 (COX-2) in endothelial cells of the OVLT, leading to PGE2 synthesis, which binds to EP3 receptors on VMPO neurons. This binding shifts the thermal sensitivity of these neurons, raising the set point to a higher temperature (often 38–40°C), prompting the body to generate and conserve heat until the new equilibrium is reached.[1][38] To achieve the elevated set point, the hypothalamus activates specific thermoeffector pathways. Vasoconstriction of cutaneous blood vessels reduces heat loss to the environment by minimizing blood flow to the skin, while behavioral responses like seeking warmth may also be elicited. For heat production, shivering thermogenesis involves rhythmic contractions of skeletal muscles coordinated via descending pathways from the hypothalamus to the spinal cord, generating metabolic heat. In infants, non-shivering thermogenesis predominates, occurring in brown adipose tissue through uncoupling protein-1 (UCP-1)-mediated proton leak in mitochondria, which is sympathetically stimulated by the hypothalamus.[1][38] Fever resolution involves negative feedback loops that restore the set point to normal once the underlying stimulus diminishes. As circulating pyrogens decrease, PGE2 levels fall, allowing EP3 receptor activity to wane and thermosensitive neurons to regain their baseline sensitivity. Additionally, warmth-sensitive neurons in the preoptic area, such as those expressing prostaglandin D synthase (Ptgds), detect the elevated core temperature and release prostaglandin D2 (PGD2), which acts on DP1 receptors to suppress heat-generating effectors and promote cooling mechanisms like vasodilation and sweating. This circuit ensures precise control, preventing excessive hyperthermia and facilitating a return to euthermia.[1][39]Pyrogens
Pyrogens are substances that trigger the febrile response by acting on the body's thermoregulatory system. They are broadly classified into endogenous pyrogens, which are produced internally by the host, and exogenous pyrogens, which originate from external sources such as microorganisms.[1] Endogenous pyrogens primarily consist of proinflammatory cytokines released by immune cells, including monocytes, macrophages, and endothelial cells, in response to infection, tissue damage, or inflammatory stimuli. Key examples include interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), which are synthesized and secreted during the acute-phase response to elevate body temperature. These cytokines act as mediators that signal the central nervous system to initiate fever.[40][41] Exogenous pyrogens are microbial components that directly or indirectly provoke the release of endogenous pyrogens. Prominent among them are lipopolysaccharide (LPS), also known as endotoxin, derived from the outer membrane of Gram-negative bacteria, and lipoteichoic acid from the cell walls of Gram-positive bacteria. These pathogen-associated molecular patterns bind to toll-like receptors on immune cells, triggering cytokine production and subsequent fever induction.[42][1] The mechanism by which pyrogens induce fever involves their interaction with the blood-brain barrier (BBB) or peripheral sites to promote the synthesis of prostaglandin E2 (PGE2). Circulating pyrogens, such as cytokines, can cross the BBB at circumventricular organs or induce PGE2 production in endothelial cells via activation of cyclooxygenase (COX) enzymes, particularly COX-2, leading to elevated hypothalamic set-point temperature. Exogenous pyrogens similarly stimulate this pathway indirectly through cytokine release.[1][43] Beyond infectious causes, non-infectious conditions can also elicit fever through the release of endogenous pyrogens. Tissue injury from trauma or surgery prompts macrophage activation and cytokine secretion, while malignancies, such as lymphomas or solid tumors, produce pyrogenic cytokines either directly from tumor cells or via associated inflammation. Autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus, involve dysregulated immune responses that elevate IL-1, IL-6, and TNF-α levels, contributing to persistent fever.[1][40]Neural Mechanisms
The neural mechanisms of fever involve integrated afferent signaling that detects peripheral pyrogens, central processing via prostaglandin E2 (PGE2), and efferent outputs that elevate body temperature to match the new hypothalamic set point. Peripheral pyrogens, such as cytokines, initiate the cascade by activating sensory pathways that convey inflammatory signals to the brain.[44] Afferent pathways primarily include the vagus nerve and circumventricular organs, which detect circulating pyrogens and transmit signals to the preoptic area of the hypothalamus. The vagus nerve serves as a rapid neural route, where cytokines like IL-1β activate vagal afferent fibers innervating peripheral sites of inflammation, relaying pyrogenic messages directly to the brainstem and onward to thermoregulatory centers.[45] Circumventricular organs, particularly the organum vasculosum of the lamina terminalis (OVLT), lack a complete blood-brain barrier and sense blood-borne cytokines, projecting neurons to the median preoptic nucleus to initiate fever signaling.[45][44] Within the brain, PGE2, synthesized by endothelial cells in the hypothalamus via cyclooxygenase-2 and microsomal PGE synthase-1, acts as the key mediator by binding to EP3 receptors on warm-sensitive neurons in the preoptic area, thereby raising the thermoregulatory set point and triggering heat conservation and production.[44] This binding disinhibits downstream neurons, integrating afferent inputs to coordinate the febrile response.[44] Efferent outputs from the preoptic area drive thermogenesis through sympathetic and somatic pathways. Sympathetic activation occurs via projections to the dorsomedial hypothalamus and rostral medullary raphe, stimulating vasoconstriction, piloerection, and non-shivering thermogenesis in brown adipose tissue to reduce heat loss and increase production.[46] Somatic motor pathways, also originating from the dorsomedial hypothalamus, engage shivering thermogenesis by exciting spinal motor neurons innervating skeletal muscles, particularly during pronounced fever.[46] Fever resolution involves anti-pyretic neural signals that dampen the inflammatory cascade, such as interleukin-10 (IL-10), which suppresses pro-inflammatory cytokine production and thereby reduces PGE2 synthesis and EP3 receptor activation.[47] This feedback mechanism restores the thermoregulatory set point once the pyrogenic stimulus subsides.[44]Differential Diagnosis
Hyperthermia
Hyperthermia is characterized by an unregulated elevation in core body temperature resulting from excessive heat production or impaired heat dissipation, without any alteration in the hypothalamic set point, in contrast to the regulated rise seen in fever.[1] This condition typically occurs when environmental factors, physical exertion, or pharmacological influences overwhelm the body's thermoregulatory mechanisms, leading to temperatures often exceeding 40°C.[38] Common causes of hyperthermia include heatstroke, which is divided into classic (non-exertional) and exertional forms. Classic heatstroke arises from prolonged exposure to high ambient temperatures, particularly in vulnerable populations such as the elderly or those with chronic illnesses, where impaired sweating and vasodilation fail to dissipate heat effectively.[48] Exertional heatstroke, on the other hand, stems from intense physical activity in hot environments, causing rapid internal heat generation that surpasses cooling capacity, often affecting young, healthy individuals like athletes.[49] Other notable causes are malignant hyperthermia, a genetic disorder triggered by certain anesthetics (e.g., halothane or succinylcholine) that provoke uncontrolled skeletal muscle contractions and heat release,[50] and neuroleptic malignant syndrome, a rare but life-threatening reaction to antipsychotic medications like haloperidol, involving dopamine blockade that disrupts thermoregulation and leads to muscle rigidity and hyperthermia.[51] Pathophysiologically, hyperthermia induces direct cellular damage through protein denaturation, membrane instability, and disruption of enzymatic functions, culminating in widespread cytotoxicity, inflammation, and multi-organ dysfunction, unlike the adaptive, immune-enhancing response of fever.[33] At temperatures above 40°C, this can trigger apoptosis, coagulation abnormalities, and endothelial injury, exacerbating systemic collapse.[52] Clinically, hyperthermia differs from fever by the absence of chills or rigors, as there is no hypothalamic-mediated drive to elevate temperature; instead, it presents with rapid onset of symptoms like confusion, seizures, and hot, dry skin due to anhidrosis in severe cases.[53] Mortality is notably higher, reaching up to 70% in untreated severe heatstroke, owing to the unchecked progression to irreversible organ failure.[54]Infectious vs Non-Infectious Causes
In community and outpatient settings, particularly among otherwise healthy children and adults, the vast majority of fevers are caused by viral infections. Common examples include upper respiratory tract infections (such as the common cold or influenza), gastroenteritis (stomach bugs), COVID-19, and other self-limited viral illnesses. Bacterial infections (e.g., strep throat, urinary tract infections, pneumonia, or ear infections) occur less frequently in this population and often present with localizing symptoms. In children, viral causes predominate even more prominently, with bacterial infections like otitis media or UTIs as secondary considerations. In contrast, among hospitalized patients, infectious causes still predominate but with a higher proportion of severe bacterial infections; sepsis accounts for up to 74% of fevers in this setting [33], alongside other bacterial, viral, or fungal sources. Non-infectious causes (autoimmune disorders, malignancies, drug reactions, etc.) become more relevant in prolonged or unexplained fevers regardless of setting. This distinction highlights that while infection is the most common overall trigger for fever, viral etiologies drive most everyday cases in healthy individuals. Non-infectious causes encompass autoimmune disorders, malignancies, drug reactions, and factitious fever. Autoimmune conditions such as rheumatoid arthritis or systemic lupus erythematosus can manifest with persistent low-grade fever due to inflammatory cytokines.[55] Malignancies, including lymphoma or renal cell carcinoma, often present with fever as a paraneoplastic syndrome.[56] Drug-induced fever, commonly associated with antibiotics like beta-lactams, results from hypersensitivity reactions and accounts for up to 3% of hospital admissions for fever.[55] Factitious fever involves intentional self-induction, typically through manipulation of thermometers or injection of contaminants.[57] Geographic factors influence the prevalence of infectious causes, with tropical regions showing higher rates of vector-borne diseases like dengue fever and malaria due to environmental suitability for vectors.[58] In contrast, temperate climates more commonly feature bacterial infections such as streptococcal pharyngitis or community-acquired pneumonia.[4] A subset of fevers defies initial classification, termed fever of unknown origin (FUO), defined by a temperature exceeding 38.3°C on multiple occasions, lasting more than three weeks, and remaining undiagnosed after at least one week of investigation.[57] In FUO among adults, infectious etiologies comprise 20% to 40% of diagnosed cases, noninfectious inflammatory diseases 10% to 30%, malignancies 20% to 30%, and miscellaneous causes 10% to 20%, with up to 50% resolving without a definitive diagnosis.[56]Diagnostic Approach
Clinical Evaluation
The clinical evaluation of fever commences with a detailed history and physical examination to ascertain the underlying cause, gauge severity, and guide further management. This bedside assessment is fundamental, as it often reveals localizing clues to infection or other etiologies without immediate recourse to ancillary tests. Normal body temperature averages 37°C (98.6°F) but varies by site and time of day, with fever defined as a rectal temperature ≥38°C in most contexts.[6][57] History taking focuses on the fever's onset, which may be sudden in bacterial infections or gradual in viral ones, alongside its duration and pattern—such as intermittent spikes, sustained elevation, or relapsing cycles that can suggest specific conditions like malaria. Associated symptoms, including chills, sweats, headache, cough, abdominal pain, or rash, provide critical context for differential diagnosis. Although fever can occur as the only or primary symptom in some viral infections in adults, particularly in mild cases, early stages, or certain respiratory viruses, this presentation is uncommon. Most viral infections in adults typically involve additional symptoms such as cough, sore throat, fatigue, body aches, or respiratory issues. Fever alone is less common in adults than in children for viral respiratory infections, and isolated fever without other localizing symptoms may warrant evaluation for other causes, including bacterial infections, occult processes, malignancies, or noninfectious etiologies, especially if persistent or unexplained.[59][57] Recent travel history, animal or environmental exposures, occupational risks, and contact with ill individuals are probed to identify infectious sources, while a review of medications (e.g., for drug fever) and immunization status helps exclude vaccine-related reactions or prophylaxis failures.[60][57][6] The physical examination prioritizes vital signs, with accurate temperature measurement (preferably rectal or tympanic) confirming fever, alongside pulse rate—which may show tachycardia proportional to temperature rise or relative bradycardia in certain infections—and blood pressure to detect hypotension signaling sepsis. A systematic head-to-toe survey seeks focal signs of infection, such as rash (e.g., petechial in meningococcemia), cervical or generalized lymphadenopathy, pharyngeal erythema, abdominal tenderness indicating peritonitis, or joint swelling in rheumatic fever. Skin turgor and mucous membranes are assessed for dehydration, a common complication.[60][57][6] Red flags warranting urgent attention include fever exceeding 40°C (hyperpyrexia), which risks organ damage; altered mental status such as confusion or lethargy, indicating possible encephalitis or systemic involvement; and neck stiffness, a hallmark of meningitis requiring immediate evaluation. These findings prompt expedited intervention to avert complications.[57][61] Approaches must be tailored by age. In neonates and young infants (under 60 days), any fever ≥38°C triggers a high index of suspicion for sepsis, necessitating meticulous assessment of feeding, activity, and subtle signs like irritability or poor perfusion, often leading to full sepsis workup. For older children and adults, evaluation emphasizes nuanced history elements; adults, in particular, require detailed travel and exposure queries to uncover exotic pathogens like dengue or typhoid.[61][60][57]Laboratory and Imaging
Laboratory evaluation of fever begins with basic tests to identify common infectious or inflammatory causes. A complete blood count (CBC) with differential is routinely performed, where leukocytosis, often with a predominance of neutrophils, suggests bacterial infection.[62] C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) serve as non-specific markers of inflammation, with elevated levels indicating ongoing systemic response, though they lack specificity for etiology.[63] Blood cultures, ideally obtained from multiple sites before antibiotic administration, are essential for detecting bacteremia, with three sets recommended to improve yield.[57] Urinalysis with microscopy and culture helps rule out urinary tract infections, a frequent source of fever.[57] Advanced laboratory tests are selected based on clinical suspicion to target specific pathogens. Polymerase chain reaction (PCR) assays detect viral nucleic acids in respiratory or cerebrospinal fluid samples, aiding diagnosis of viral etiologies like enterovirus or parechovirus in cases without an apparent source.[64] Serologic testing for antibodies against agents such as HIV or Epstein-Barr virus (EBV) is useful in prolonged or atypical fevers, where positive results confirm prior exposure or acute infection.[65] Imaging modalities complement laboratory findings by visualizing structural abnormalities. Chest X-ray (CXR) is a first-line test for suspected pneumonia, particularly in febrile patients with respiratory symptoms, offering high sensitivity for infiltrates.[66] Computed tomography (CT) scans of the chest, abdomen, or pelvis detect occult abscesses or other focal infections not apparent on plain films.[67] In fever of unknown origin (FUO), defined as fever exceeding 38.3°C for at least three weeks with negative initial evaluation, a stepwise diagnostic approach is employed. Initial non-invasive tests include CBC, CRP, ESR, blood cultures, urinalysis, CXR, and CT; if inconclusive, antinuclear antibody (ANA) testing screens for autoimmune disorders like systemic lupus erythematosus.[57] Fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) is increasingly used early in the workup for its ability to identify occult malignancies, infections, or inflammatory foci with high sensitivity.[68] These tests have inherent limitations that must be considered. Blood cultures and PCR can yield false negatives in early infections due to low bacterial or viral loads before systemic dissemination.[69] In low-risk cases without suggestive history or exam findings, extensive testing may lack cost-effectiveness, potentially leading to unnecessary expenses without altering management.[70]Fever Patterns and Types
Fever Curves
Fever curves represent the graphical depiction of body temperature fluctuations over time during a febrile episode, providing insights into the underlying physiological dynamics. These patterns arise from periodic shifts in the hypothalamic set point, which dictate the body's thermoregulatory response to pyrogenic stimuli.[1] To construct a fever curve, serial temperature measurements are typically taken every 4 to 6 hours over 24 to 72 hours, using consistent methods such as oral or rectal thermometry for accuracy, allowing clinicians to identify characteristic trends rather than isolated readings.[32] The primary types of fever curves include continuous, intermittent, and remittent patterns, each distinguished by the degree and timing of temperature variations. In a continuous or sustained fever, the temperature remains elevated above 38°C with minimal daily fluctuation (less than 0.3°C to 0.5°C), as seen in conditions like typhoid fever or bacterial endocarditis.[32][71] An intermittent fever features spikes above 38°C that return to normal (≤37.2°C) at least once daily, often associated with malaria or pyelonephritis, and may accompany rigors or sweats.[32][13] In contrast, a remittent fever shows wide diurnal swings (0.3°C to 1.4°C or more) while persistently staying elevated, commonly observed in viral infections or ascending cholangitis.[32][71] Certain variants, such as hectic fever—a subtype of intermittent or remittent with exaggerated swings exceeding 1.4°C—indicate more severe processes, including bacterial septicemia, deep-seated abscesses, or tuberculosis.[71][32] These patterns hold clinical utility in narrowing differential considerations: for instance, intermittent curves may suggest an abscess or malaria, while hectic fluctuations point toward sepsis or peritonitis, and a diurnal rhythm—where temperature peaks in the evening—is typical in tuberculosis, sometimes with reversal of the normal pattern in disseminated cases. In many infections, fever commonly peaks in the evening or at night due to circadian rhythm influences on body temperature regulation, with large-scale data showing febrile temperatures peaking between 8 PM and 3 AM. In children particularly, nocturnal spikes are frequent, reflecting the natural evening rise in core body temperature combined with lower nocturnal cortisol levels that reduce anti-inflammatory suppression and allow intensified immune responses to infections, typically viral or bacterial. This pattern is especially noticeable in young children around 2 years of age due to immature thermoregulation, with core body temperature naturally lowest in the morning and rising by approximately 0.5°C in the evening and night, making fever appear or intensify at night. It is frequently associated with viral infections such as common colds, where reduced anti-inflammatory hormones at night exacerbate the fever. This is a common physiological pattern rather than a separate illness or sign of worsening condition; however, persistent high fever (≥38°C for several days) or accompanying symptoms (such as ear pain or respiratory distress) may indicate bacterial infections (e.g., otitis media or pneumonia) and requires medical attention.[72][73] However, fever curves alone are not diagnostic and must integrate with other clinical findings. Advancements in monitoring have introduced wearable devices, such as patch-based or wrist-worn sensors, enabling real-time tracking of temperature curves in ambulatory settings for early detection of febrile episodes without frequent hospital visits.[74] These tools, validated for continuous physiological surveillance, facilitate remote management in outpatient care, particularly for chronic or at-risk patients.[75]Hyperpyrexia
Hyperpyrexia is defined as a body temperature exceeding 41°C (105.8°F), representing an extreme elevation beyond the normal hypothalamic thermoregulatory set point and distinguishing it from standard fevers. Temperatures reaching or exceeding 42°C (107.6°F) constitute a particularly critical phase of hyperpyrexia, representing a medical emergency that risks brain damage, organ failure, and death if sustained.[76][1][77] This condition often arises from overwhelming infections, such as bacterial sepsis, where systemic inflammatory responses disrupt thermoregulation, or central nervous system disorders like encephalitis, which directly impair hypothalamic function. Drug reactions, including salicylate toxicity, can also induce hyperpyrexia by uncoupling oxidative phosphorylation and interfering with heat dissipation mechanisms.[78][79][80] Hyperpyrexia accelerates complications, including disseminated intravascular coagulation (DIC) due to endothelial damage and widespread clotting activation, as well as cerebral edema from vascular permeability changes and neuronal stress. These risks intensify at temperatures of 42°C and above, where direct cellular toxicity from severe heat exposure can cause irreversible tissue injury, exacerbating multi-organ failure.[76][77] The prognosis for hyperpyrexia is grave in severe cases, particularly those linked to sepsis or CNS involvement, far exceeding outcomes for typical fevers due to the rapid progression of tissue injury.[1]Biological Role
Immune Enhancement
Fever plays an adaptive role in enhancing immune defenses by optimizing various cellular and molecular processes at elevated core temperatures, typically in the range of 38–40°C. One key mechanism involves accelerated neutrophil migration to sites of infection, where febrile temperatures upregulate chemokines such as CXCL8 (IL-8) via heat shock factor 1 (HSF1), promoting neutrophil extravasation, respiratory burst, and bacteriolytic activity in the lungs.[81] Additionally, fever-range hyperthermia boosts T-cell proliferation and effector differentiation by enhancing L-selectin shedding and ICAM-1 expression on high endothelial venules, facilitating greater T-cell trafficking and IL-6 trans-signaling across vertebrate species.[82] Interferon production is also amplified at these temperatures, with dendritic cells exhibiting increased interferon-α (IFN-α) secretion in response to viral stimuli, thereby strengthening antiviral adaptive immunity.[83] Fever further triggers heat shock proteins that protect host cells from stress and augment immune responses by acting as danger signals to activate antigen-presenting cells and enhance pathogen clearance.[84][85] Beyond direct immune cell modulation, fever inhibits pathogen proliferation through thermal disruption of microbial processes. For bacteria, elevated temperatures denature toxins and enhance antibiotic efficacy, with studies demonstrating progressive antimicrobial activity from 35°C to 41.5°C.[86] In viral infections, fever slows replication by altering membrane fluidity and endosomal pH, impeding virion entry; for instance, rhinovirus, which replicates optimally at 33°C in the cooler nasal passages, experiences reduced genome synthesis and assembly at 38–40°C.[87] Supporting evidence from animal models underscores these benefits, showing that mild fever confers higher survival rates during infection. In lizards infected with Aeromonas hydrophila, maintaining body temperatures at 40–42°C post-infection significantly improved survival compared to 34–36°C, highlighting fever's protective role without metabolic overload.[88] Human studies further suggest that suppressing fever with antipyretics can prolong illness in certain infections; for example, in volunteers experimentally infected with rhinovirus, aspirin, acetaminophen, or ibuprofen reduced antibody responses, increased nasal symptoms, and trended toward extended viral shedding.[89] The evolutionary conservation of fever across vertebrates, spanning over 600 million years, indicates a strong selective advantage in pathogen defense. This trait, observed from fish to mammals, enhances immune efficiency and infection resolution, outweighing energetic costs in natural settings.[1]Effects on Adaptive Immunity
Fever not only stresses pathogens but also directly modulates adaptive immune responses, particularly benefiting cytotoxic T cells (also known as CD8+ T cells or killer T cells). Exposure to fever-range temperatures (typically 39–40°C) enhances several aspects of CD8+ T cell function:- Enhanced differentiation: Mild hyperthermia promotes the differentiation of naïve CD8+ T cells into effector cells, characterized by downregulation of CD62L and upregulation of CD44, leading to a higher proportion of potent effector cells capable of IFN-γ production and cytotoxicity.
- Increased cytotoxicity and cytokine production: Effector CD8+ T cells exposed to febrile temperatures show augmented IFN-γ secretion and improved killing of target cells, partly through mechanisms like increased membrane fluidity, clustering of TCR and CD8 coreceptors in cholesterol-rich microdomains, and faster conjugate formation with antigen-presenting cells.
- Metabolic and proliferative boosts: Febrile conditions increase mitochondrial mass and metabolic activity in activated CD8+ T cells, supporting higher energy demands for proliferation and effector functions. While some T cell subsets experience mitochondrial stress and selective apoptosis (e.g., certain Th1-like responses), surviving cells adapt with enhanced resistance and inflammatory activity.
- Trafficking and homing: Fever-range heat improves T cell adhesion and migration to lymphoid organs and inflamed tissues.